speb/financial-data huggingface dataset:
CRGO balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -211000.00
CRGO income_statement (annual, 2024-12-31) — General And Administrative Expense: 19902000.00
CRGO income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 11595000.00
CRGO balance_sheet (annual, 2024-12-31) — Goodwill: 15040000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Goodwill: 15040000.00
CRGO balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 23892000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 23892000.00
CRGO balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 3304000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 3304000.00
CRGO balance_sheet (annual, 2024-12-31) — Gross PPE: 6154000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Gross PPE: 6154000.00
CRGO income_statement (annual, 2024-12-31) — Gross Profit: 15500000.00
CRGO income_statement (quarterly, 2024-12-31) — Gross Profit: 4453000.00
CRGO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 3000000.00
CRGO income_statement (annual, 2024-12-31) — Insurance And Claims: 1067000.00
CRGO income_statement (annual, 2024-12-31) — Interest Expense: 178000.00
CRGO income_statement (quarterly, 2024-12-31) — Interest Expense: 23000.00
CRGO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 178000.00
CRGO income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 23000.00
CRGO income_statement (annual, 2024-12-31) — Interest Income: 2211000.00
CRGO income_statement (quarterly, 2024-12-31) — Interest Income: 282000.00
CRGO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 2211000.00
CRGO income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 282000.00
CRGO cash_flow (annual, 2024-12-31) — Interest Received Cfo: 2642000.00
CRGO cash_flow (quarterly, 2024-12-31) — Interest Received Cfo: 99000.00
CRGO balance_sheet (annual, 2024-12-31) — Invested Capital: 54888000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Invested Capital: 54888000.00
CRGO cash_flow (annual, 2024-12-31) — Investing Cash Flow: 2078000.00
CRGO cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -68000.00
CRGO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRGO cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CRGO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
CRGO balance_sheet (annual, 2024-12-31) — Leases: 976000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Leases: 976000.00
CRGO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 339000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 339000.00
CRGO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 339000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 339000.00
CRGO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -629000.00
CRGO cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -208000.00
CRGO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1208000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1208000.00
CRGO balance_sheet (annual, 2024-12-31) — Minimum Pension Liabilities: 96000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Minimum Pension Liabilities: 96000.00
CRGO cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: -3350000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Business Purchase And Sale: 0.00
CRGO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CRGO income_statement (annual, 2024-12-31) — Net Income: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -9837000.00
CRGO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -22491000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -22491000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -9837000.00
CRGO income_statement (annual, 2024-12-31) — Net Interest Income: 2033000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Interest Income: 259000.00
CRGO cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 5474000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Investment Purchase And Sale: -75000.00
CRGO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -629000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -208000.00
CRGO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -629000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -208000.00
CRGO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 2033000.00
CRGO income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 259000.00
CRGO balance_sheet (annual, 2024-12-31) — Net PPE: 1611000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Net PPE: 1611000.00
CRGO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -46000.00
CRGO cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -16000.00
CRGO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CRGO cash_flow (quarterly, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CRGO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 30996000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 30996000.00
CRGO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 536000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Assets: 536000.00
CRGO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 536000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Assets: 536000.00
CRGO balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1239000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1239000.00
CRGO balance_sheet (annual, 2024-12-31) — Non Current Prepaid Assets: 1637000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 1637000.00
CRGO income_statement (annual, 2024-12-31) — Normalized EBITDA: -14653000.00
CRGO income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -3885000.00
CRGO income_statement (annual, 2024-12-31) — Normalized Income: -19358650.00
CRGO income_statement (quarterly, 2024-12-31) — Normalized Income: -6353100.00
CRGO cash_flow (annual, 2024-12-31) — Operating Cash Flow: -12100000.00
CRGO cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: -4529000.00
CRGO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 965000.00
CRGO cash_flow (quarterly, 2024-12-31) — Operating Gains Losses: 1410000.00
CRGO income_statement (annual, 2024-12-31) — Operating Income: -19947000.00
CRGO income_statement (quarterly, 2024-12-31) — Operating Income: -5037000.00
CRGO income_statement (annual, 2024-12-31) — Operating Revenue: 23785000.00
CRGO income_statement (quarterly, 2024-12-31) — Operating Revenue: 6587000.00
CRGO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 49726906.00
CRGO balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 49726906.00
CRGO balance_sheet (annual, 2024-12-31) — Other Current Assets: 4494000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 4494000.00
CRGO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 6944000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 6944000.00
CRGO income_statement (annual, 2024-12-31) — Other Gand A: 3652000.00
CRGO income_statement (quarterly, 2024-12-31) — Other Gand A: -4655000.00
CRGO income_statement (annual, 2024-12-31) — Other Income Expense: -3965000.00
CRGO income_statement (quarterly, 2024-12-31) — Other Income Expense: -4410000.00
CRGO balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 8852000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 8852000.00
CRGO cash_flow (annual, 2024-12-31) — Other Non Cash Items: -1682000.00
CRGO cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: -259000.00
CRGO balance_sheet (annual, 2024-12-31) — Other Payable: 1050000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Payable: 1050000.00
CRGO balance_sheet (annual, 2024-12-31) — Other Receivables: 603000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Receivables: 603000.00
CRGO balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 27153000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Other Short Term Investments: 27153000.00
CRGO balance_sheet (annual, 2024-12-31) — Payables: 3781000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Payables: 3781000.00
CRGO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 6607000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 6607000.00
CRGO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 650000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 650000.00
CRGO income_statement (annual, 2024-12-31) — Pretax Income: -21879000.00
CRGO income_statement (quarterly, 2024-12-31) — Pretax Income: -9188000.00
CRGO cash_flow (annual, 2024-12-31) — Proceeds From Stock Option Exercised: 714000.00
CRGO cash_flow (quarterly, 2024-12-31) — Proceeds From Stock Option Exercised: 411000.00
CRGO cash_flow (annual, 2024-12-31) — Purchase Of Business: -3350000.00
CRGO cash_flow (quarterly, 2024-12-31) — Purchase Of Business: 0.00
CRGO cash_flow (annual, 2024-12-31) — Purchase Of Investment: -26070000.00
CRGO cash_flow (quarterly, 2024-12-31) — Purchase Of Investment: -70000.00
CRGO cash_flow (annual, 2024-12-31) — Purchase Of PPE: -48000.00
CRGO cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -16000.00
CRGO balance_sheet (annual, 2024-12-31) — Receivables: 3688000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Receivables: 3688000.00
CRGO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 6611000.00
CRGO income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 2134000.00
CRGO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 3083000.00
CRGO income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 870000.00
CRGO income_statement (annual, 2024-12-31) — Rent And Landing Fees: 693000.00
CRGO income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 693000.00
CRGO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -629000.00
CRGO cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -208000.00
CRGO income_statement (annual, 2024-12-31) — Research And Development: 10275000.00
CRGO income_statement (quarterly, 2024-12-31) — Research And Development: 2817000.00
CRGO income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CRGO income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CRGO balance_sheet (annual, 2024-12-31) — Retained Earnings: -206670000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Retained Earnings: -206670000.00
CRGO income_statement (annual, 2024-12-31) — Salaries And Wages: 14490000.00
CRGO cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CRGO cash_flow (annual, 2024-12-31) — Sale Of Investment: 31544000.00
CRGO cash_flow (quarterly, 2024-12-31) — Sale Of Investment: -5000.00
CRGO cash_flow (annual, 2024-12-31) — Sale Of PPE: 2000.00
CRGO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
CRGO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 3861000.00
CRGO income_statement (quarterly, 2024-12-31) — Selling And Marketing Expense: -6331000.00
CRGO income_statement (annual, 2024-12-31) — Selling General And Administration: 23763000.00
CRGO income_statement (quarterly, 2024-12-31) — Selling General And Administration: 5264000.00
CRGO balance_sheet (annual, 2024-12-31) — Share Issued: 49726906.00
CRGO balance_sheet (quarterly, 2024-12-31) — Share Issued: 49726906.00
CRGO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
CRGO cash_flow (annual, 2024-12-31) — Short Term Debt Payments: 0.00
CRGO cash_flow (quarterly, 2024-12-31) — Short Term Debt Payments: 0.00
CRGO income_statement (annual, 2024-12-31) — Special Income Charges: -3000000.00
CRGO income_statement (quarterly, 2024-12-31) — Special Income Charges: -3000000.00
CRGO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 3625000.00
CRGO cash_flow (quarterly, 2024-12-31) — Stock Based Compensation: 1049000.00
CRGO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 54888000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 54888000.00
CRGO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 30996000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 30996000.00
CRGO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -832650.00
CRGO income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: -926100.00
CRGO income_statement (annual, 2024-12-31) — Tax Provision: 612000.00
CRGO income_statement (quarterly, 2024-12-31) — Tax Provision: 649000.00
CRGO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.21
CRGO income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.21
CRGO cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -343000.00
CRGO cash_flow (quarterly, 2024-12-31) — Taxes Refund Paid: -137000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Assets: 73779000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Assets: 73779000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Capitalization: 54888000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 54888000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Debt: 954000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Debt: 954000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 54888000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 54888000.00
CRGO income_statement (annual, 2024-12-31) — Total Expenses: 43732000.00
CRGO income_statement (quarterly, 2024-12-31) — Total Expenses: 11624000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 18891000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 18891000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 27676000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 27676000.00
CRGO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1578000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 1578000.00
CRGO income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -22947000.00
CRGO income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -8037000.00
CRGO income_statement (annual, 2024-12-31) — Total Unusual Items: -3965000.00
CRGO income_statement (quarterly, 2024-12-31) — Total Unusual Items: -4410000.00
CRGO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -3965000.00
CRGO income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -4410000.00
CRGO balance_sheet (annual, 2024-12-31) — Working Capital: 28790000.00
CRGO balance_sheet (quarterly, 2024-12-31) — Working Capital: 28790000.00
CRGO income_statement (quarterly, 2025-03-31) — +Operating Expense: 9320000.00
CRGO income_statement (quarterly, 2025-03-31) — +Total Revenue: 6945000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 5653000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 3821000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 262729000.00
CRGO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 49881927.00
CRGO income_statement (quarterly, 2025-03-31) — Basic EPS: -0.09
CRGO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 10118000.00
CRGO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -16000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 1907000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 36437000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 36437000.00
CRGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 113000.00
CRGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 25891000.00
CRGO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 290000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 2936000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: -305000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 1168000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -1168000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Payable: 2936000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 2631000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Receivables: -935000.00
CRGO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 1696000.00
CRGO cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -701000.00
CRGO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 26294000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Common Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 51540000.00
CRGO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 2306000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 6870000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Current Assets: 45322000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 719000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 719000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 19261000.00
CRGO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 55000.00
CRGO cash_flow (quarterly, 2025-03-31) — Deferred Tax: 55000.00
CRGO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 938000.00
CRGO cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 938000.00
CRGO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 49881927.00
CRGO income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.09
CRGO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — EBIT: -4329000.00
CRGO income_statement (quarterly, 2025-03-31) — EBITDA: -3391000.00
CRGO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 25000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 1303000.00
CRGO cash_flow (quarterly, 2025-03-31) — End Cash Position: 36437000.00
CRGO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 113000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Foreign Currency Translation Adjustments: -117000.00
CRGO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 274000.00
CRGO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 223000.00
CRGO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: -223000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -21000.00
CRGO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 2754000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Goodwill: 15135000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 23503000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 2347000.00
CRGO income_statement (quarterly, 2025-03-31) — Gross Profit: 4639000.00
CRGO income_statement (quarterly, 2025-03-31) — Interest Expense: 115000.00
CRGO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 115000.00
CRGO income_statement (quarterly, 2025-03-31) — Interest Income: 575000.00
CRGO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 575000.00
CRGO cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 1533000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 51540000.00
CRGO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: 25891000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 1188000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1188000.00
CRGO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -151000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Minimum Pension Liabilities: 96000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -4499000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -4499000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Interest Income: 460000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 26000000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -151000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -151000.00
CRGO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 460000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -118000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Net PPE: 2347000.00
CRGO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 9000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 28037000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 502000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 502000.00
CRGO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -3168000.00
CRGO income_statement (quarterly, 2025-03-31) — Normalized Income: -4322830.00
CRGO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 290000.00
CRGO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 223000.00
CRGO income_statement (quarterly, 2025-03-31) — Operating Income: -4681000.00
CRGO income_statement (quarterly, 2025-03-31) — Operating Revenue: 6945000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 50595118.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 3346000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 6019000.00
CRGO income_statement (quarterly, 2025-03-31) — Other Gand A: 2754000.00
CRGO income_statement (quarterly, 2025-03-31) — Other Income Expense: -223000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 8368000.00
CRGO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -460000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1618000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Properties: 2347000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1718000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 0.00
CRGO balance_sheet (quarterly, 2025-03-31) — Payables: 5653000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 12523000.00
CRGO income_statement (quarterly, 2025-03-31) — Pretax Income: -4444000.00
CRGO cash_flow (quarterly, 2025-03-31) — Proceeds From Stock Option Exercised: 264000.00
CRGO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -16000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Receivables: 5539000.00
CRGO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 2306000.00
CRGO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 938000.00
CRGO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -151000.00
CRGO income_statement (quarterly, 2025-03-31) — Research And Development: 2883000.00
CRGO income_statement (quarterly, 2025-03-31) — Restructuring And Mergern Acquisition: 0.00
CRGO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -211169000.00
CRGO cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 26000000.00
CRGO cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 25000.00
CRGO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 3683000.00
CRGO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 6437000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Share Issued: 50595118.00
CRGO income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CRGO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 697000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 51540000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 28037000.00
CRGO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -46830.00
CRGO income_statement (quarterly, 2025-03-31) — Tax Provision: 55000.00
CRGO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.21
CRGO cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: 107000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Assets: 73292000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 51540000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Debt: 1907000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 51540000.00
CRGO income_statement (quarterly, 2025-03-31) — Total Expenses: 11626000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 21752000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 27970000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2491000.00
CRGO income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -4681000.00
CRGO income_statement (quarterly, 2025-03-31) — Total Unusual Items: -223000.00
CRGO income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -223000.00
CRGO balance_sheet (quarterly, 2025-03-31) — Working Capital: 26061000.00
CRGO income_statement (quarterly, 2025-06-30) — +Operating Expense: 9507000.00
CRGO income_statement (quarterly, 2025-06-30) — +Total Revenue: 7438000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 5666000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 4043000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 263799000.00
CRGO income_statement (quarterly, 2025-06-30) — Basic Average Shares: 50291610.00
CRGO income_statement (quarterly, 2025-06-30) — Basic EPS: -0.09
CRGO cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 36437000.00
CRGO cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -58000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 1987000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 19981000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 34149000.00
CRGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 76000.00
CRGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -13947000.00
CRGO cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -2822000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Account Payable: -74000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Accrued Expense: 525000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 20000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -93000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Payable: -74000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 451000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Receivables: -338000.00
CRGO cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 40000.00
CRGO cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -77000.00
CRGO cash_flow (quarterly, 2025-06-30) — Changes In Cash: -16693000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Common Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 48765000.00
CRGO income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 2445000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 7612000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Current Assets: 43823000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 832000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 832000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 20366000.00
CRGO cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 38000.00
CRGO cash_flow (quarterly, 2025-06-30) — Deferred Tax: 38000.00
CRGO cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 806000.00
CRGO cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 806000.00
CRGO income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 50291610.00
CRGO income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.09
CRGO income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — EBIT: -4221000.00
CRGO income_statement (quarterly, 2025-06-30) — EBITDA: -3415000.00
CRGO cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 237000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 1349000.00
CRGO cash_flow (quarterly, 2025-06-30) — End Cash Position: 19981000.00
CRGO cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 76000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Foreign Currency Translation Adjustments: 316000.00
CRGO cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -2880000.00
CRGO cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 285000.00
CRGO income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: -285000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 412000.00
CRGO income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 2623000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Goodwill: 15343000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 23361000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Gross PPE: 2306000.00
CRGO income_statement (quarterly, 2025-06-30) — Gross Profit: 4993000.00
CRGO income_statement (quarterly, 2025-06-30) — Interest Expense: 19000.00
CRGO income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 19000.00
CRGO income_statement (quarterly, 2025-06-30) — Interest Income: 578000.00
CRGO income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 578000.00
CRGO cash_flow (quarterly, 2025-06-30) — Interest Received Cfo: 111000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Invested Capital: 48765000.00
CRGO cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -13947000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 1155000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 1155000.00
CRGO cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -149000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Minimum Pension Liabilities: 96000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4278000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4278000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Interest Income: 559000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -14007000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -149000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -149000.00
CRGO income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 559000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 111000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Net PPE: 2306000.00
CRGO cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -58000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 25404000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 519000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 519000.00
CRGO income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -3130000.00
CRGO income_statement (quarterly, 2025-06-30) — Normalized Income: -4052850.00
CRGO cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -2822000.00
CRGO cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 285000.00
CRGO income_statement (quarterly, 2025-06-30) — Operating Income: -4514000.00
CRGO income_statement (quarterly, 2025-06-30) — Operating Revenue: 7438000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 50595118.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 3298000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 6256000.00
CRGO income_statement (quarterly, 2025-06-30) — Other Gand A: 2623000.00
CRGO income_statement (quarterly, 2025-06-30) — Other Income Expense: -285000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 8018000.00
CRGO cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: -559000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 1626000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Properties: 2306000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Receivables: 2333000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 14168000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Payables: 5666000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 13278000.00
CRGO income_statement (quarterly, 2025-06-30) — Pretax Income: -4240000.00
CRGO cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 225000.00
CRGO cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -14000000.00
CRGO cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -58000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Receivables: 6376000.00
CRGO income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 2445000.00
CRGO income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 806000.00
CRGO cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -149000.00
CRGO income_statement (quarterly, 2025-06-30) — Research And Development: 3031000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -215447000.00
CRGO cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 0.00
CRGO cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CRGO income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 3853000.00
CRGO income_statement (quarterly, 2025-06-30) — Selling General And Administration: 6476000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Share Issued: 50595118.00
CRGO cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 811000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 48765000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 25404000.00
CRGO income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -59850.00
CRGO income_statement (quarterly, 2025-06-30) — Tax Provision: 38000.00
CRGO income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.21
CRGO cash_flow (quarterly, 2025-06-30) — Taxes Refund Paid: -76000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Assets: 71635000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 48765000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Debt: 1987000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 48765000.00
CRGO income_statement (quarterly, 2025-06-30) — Total Expenses: 11952000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 22870000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 27812000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2504000.00
CRGO income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -4514000.00
CRGO income_statement (quarterly, 2025-06-30) — Total Unusual Items: -285000.00
CRGO income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -285000.00
CRGO balance_sheet (quarterly, 2025-06-30) — Working Capital: 23457000.00
CRGO income_statement (quarterly, 2025-09-30) — +Operating Expense: 9642000.00
CRGO income_statement (quarterly, 2025-09-30) — +Total Revenue: 7672000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 5313000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 4261000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 264704000.00
CRGO income_statement (quarterly, 2025-09-30) — Basic Average Shares: 50892241.00
CRGO income_statement (quarterly, 2025-09-30) — Basic EPS: -0.10
CRGO cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 19981000.00
CRGO cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -43000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 1768000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Capital Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 16290000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 30647000.00
CRGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -133000.00
CRGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -222000.00
CRGO cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -3385000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -319000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -482000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 298000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -225000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Payable: -319000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -801000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Receivables: -89000.00
CRGO cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -817000.00
CRGO cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -241000.00
CRGO cash_flow (quarterly, 2025-09-30) — Changes In Cash: -3740000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 44715000.00
CRGO income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 2368000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 7111000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Current Assets: 40059000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 667000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 667000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 19875000.00
CRGO cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 30000.00
CRGO cash_flow (quarterly, 2025-09-30) — Deferred Tax: 30000.00
CRGO cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 862000.00
CRGO cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 862000.00
CRGO income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 50892241.00
CRGO income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.10
CRGO income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — EBIT: -4859000.00
CRGO income_statement (quarterly, 2025-09-30) — EBITDA: -3997000.00
CRGO cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: 49000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 1427000.00
CRGO cash_flow (quarterly, 2025-09-30) — End Cash Position: 16290000.00
CRGO cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -133000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: 323000.00
CRGO cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3428000.00
CRGO cash_flow (quarterly, 2025-09-30) — Gain Loss On Investment Securities: 754000.00
CRGO income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: -754000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 419000.00
CRGO income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 3080000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Goodwill: 15350000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 22761000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Gross PPE: 2089000.00
CRGO income_statement (quarterly, 2025-09-30) — Gross Profit: 5304000.00
CRGO income_statement (quarterly, 2025-09-30) — Interest Expense: 73000.00
CRGO income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 73000.00
CRGO income_statement (quarterly, 2025-09-30) — Interest Income: 233000.00
CRGO income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 233000.00
CRGO cash_flow (quarterly, 2025-09-30) — Interest Received Cfo: 86000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Invested Capital: 44715000.00
CRGO cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -222000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 1101000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1101000.00
CRGO cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -227000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Minimum Pension Liabilities: 96000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net Business Purchase And Sale: 0.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -4962000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -4962000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Interest Income: 160000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -180000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -227000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -227000.00
CRGO income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 160000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Net PPE: 2089000.00
CRGO cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -42000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 21954000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 477000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 477000.00
CRGO income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -3243000.00
CRGO income_statement (quarterly, 2025-09-30) — Normalized Income: -4366340.00
CRGO cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3385000.00
CRGO cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 754000.00
CRGO income_statement (quarterly, 2025-09-30) — Operating Income: -4338000.00
CRGO income_statement (quarterly, 2025-09-30) — Operating Revenue: 7672000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 50595118.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 3072000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 6784000.00
CRGO income_statement (quarterly, 2025-09-30) — Other Gand A: 3080000.00
CRGO income_statement (quarterly, 2025-09-30) — Other Income Expense: -754000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 7411000.00
CRGO cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: -160000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 1732000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Properties: 2089000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Receivables: 2079000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 14357000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Payables: 5313000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 12424000.00
CRGO income_statement (quarterly, 2025-09-30) — Pretax Income: -4932000.00
CRGO cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 94000.00
CRGO cash_flow (quarterly, 2025-09-30) — Purchase Of Business: 0.00
CRGO cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -180000.00
CRGO cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -43000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Receivables: 6340000.00
CRGO income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 2368000.00
CRGO income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 862000.00
CRGO cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -227000.00
CRGO income_statement (quarterly, 2025-09-30) — Research And Development: 2842000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -220409000.00
CRGO cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
CRGO cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 1000.00
CRGO income_statement (quarterly, 2025-09-30) — Selling And Marketing Expense: 3720000.00
CRGO income_statement (quarterly, 2025-09-30) — Selling General And Administration: 6800000.00